Meningococcal Meningitis Treatment Market Set to Register a CAGR of 12.56% and Reach US$ 12.24 Billion by 2031 | Growth Plus Reports

Newark, New Castle, USA, April 26, 2023 (GLOBE NEWSWIRE) — According to the most recent study by Growth Plus Reports, the global Meningococcal Meningitis Treatment Market was valued at US$ 4.22 billion and is expected to register a revenue CAGR of 12.56% to reach US$ 12.24 billion by 2031.

The global market for meningococcal meningitis treatment was analyzed, and it is expected to rise significantly during the forecast period. The bacterium Neisseria meningitidis causes meningococcal meningitis, which includes infections of the brain and spinal cord lining (meningitis) and circulation, which are typically severe and can be deadly.

Request a Free Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/meningococcal-meningitis-treatment-market/8641

           Meningococcal Meningitis Treatment Market Scope

Recent Development in the Global Meningococcal Meningitis Treatment Market: 

• In May 2022, GlaxoSmithKline announced a USD 3.3 billion acquisition of privately owned biopharmaceutical business Affinivax to strengthen its vaccine pipeline, an important priority as the British drugmaker prepares to spin off its consumer division.
• In March 2022, the meningococcal vaccination trial for African neonates and young children was undertaken by the University of Maryland School of Medicine (UMSOM).

Key Takeaways: 

• The rising prevalence of meningococcal meningitis is driving the global market revenue share.
• Increasing investments by top players in treating meningococcal meningitis drive the demand for effective treatment.
• Several advancements and collaborations among market players create a strong product pipeline.

Market Drivers and Restraints: 

The driving factor for the meningococcal meningitis treatment market revenue is the rising number of burn victims and its proven effectiveness in wound management. Furthermore, manufacturers putting a strong emphasis on continuous innovation are creating advanced amorphous hydrogel dressings with enhanced features, such as antibacterial properties, greater wear life, and improved moisture control, contributing to the market revenue growth. 

However, regulatory restrictions, distribution challenges in rural areas, and a lack of awareness among the population may limit market revenue growth. 

Market Segmentation: 

Segmentation By Treatment Type

Based on treatment type, the global meningococcal meningitis treatment market is segmented into antibiotic therapy and vaccine. Due to the ability to decrease the disease burden and rising investments in discovering novel vaccines, the vaccine segment accounts for the largest market revenue share. 

Segmentation By Route of Administration

Based on the route of administration, the global meningococcal meningitis treatment market is segmented into injectables and oral. Due to its significant efficiency and rapid onset of action in treating meningitis, the injectables segment accounts for the largest revenue share.

Segmentation By Distribution Channel

Based on distribution channels, the global meningococcal meningitis treatment market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Due to the availability of a wider range of medications and resources than retail or online pharmacies, the retail pharmacies segment accounts for a sizable revenue share in the global market.

Regional Growth Dynamics

Based on the region, the global meningococcal meningitis treatment market is segmented into North America, Asia Pacific, Latin America, Europe, and the Middle East & Africa. Due to increasing incidences of meningococcal meningitis, modern healthcare infrastructure, and advantageous reimbursement policies, North America accounts for the largest revenue share in the global market.

Competitive Landscape

Following is a list of the top market players operating in the global market for meningococcal meningitis treatment: 

• Pfizer, Inc. 
• Baxter International Inc. 
• Merck & Co.
• Biomed Pvt. Ltd  
• Novartis AG
• GlaxoSmithKline Plc.

Request for Customization – https://www.growthplusreports.com/inquiry/customization/meningococcal-meningitis-treatment-market/8641

Report Coverage 

Growth Plus Reports studied the global market for meningococcal meningitis treatment in-depth and analyzed the basic market characteristics, significant investment areas, analytics of regional growth, revenue forecast, competitive market players, mergers, and acquisitions. 

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
   3. Regulatory Landscape
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL MENINGOCOCCAL MENINGITIS TREATMENT MARKET – ANALYSIS & FORECAST, BY TREATMENT TYPE
   1. Antibiotic Therapy
      1. Penicillin
      2. Ampicillin
      3. Chloramphenicol
      4. Ceftriaxone
   2. Vaccine
      1. Meningococcal Conjugate Vaccine
      2. Meningococcal Polysaccharide Vaccine
      3. Combination Vaccine
6. GLOBAL MENINGOCOCCAL MENINGITIS TREATMENT MARKET – ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
   1. Injectables
   2. Oral
7. GLOBAL MENINGOCOCCAL MENINGITIS TREATMENT MARKET – ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL 
   1. Hospital Pharmacies
   2. Retail Pharmacies
   3. Online Pharmacies

MENINGOCOCCAL MENINGITIS TREATMENT MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8641

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse Latest Healthcare Related Reports:

Lesch Nyhan Syndrome Therapeutics Market by Drug Class (Hypouricemic Agents, Benzodiazepines), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacies) – Global Outlook & Forecast 2023-2031

Hepatic Encephalopathy Treatment Market by Drug Class (Laxatives and Antibiotics), Route of Administration (Oral, Intravenous, and Rectal), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook and Forecast 2023-2031

Medical Tricorder Market by Type (Wireless, USB Camera), Application (Diagnosis, Monitoring), End User (Hospitals and Clinics, Homecare Settings) – Global Outlook & Forecast 2023-2031

Livestock Diagnostics Market by Product (Consumables, Hardware, Software), Technology (Immunodiagnostics, Molecular Diagnostics), Animal Type (Ruminants, Swine, Poultry), End User (Reference Laboratories, Diagnostic Hospitals & Clinics) – Global Outlook & Forecast 2023-2031

Ulcerative Colitis Market by Type (Ulcerative Proctitis, Proctosigmoiditis), Drug Class (Immunomodulators, Anti-inflammatory Drugs), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.